MedPath

Oracit

ORACIT Oral Citrate (Shohl's) SolutionCMP Pharma, Inc.

Approved
Approval ID

bc26abed-8e6e-475d-8ab3-abf7d0377003

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Dec 7, 2023

Manufacturers
FDA

CMP Pharma, Inc.

DUNS: 005224175

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Citric Acid and Sodium Citrate

PRODUCT DETAILS

NDC Product Code46287-014
Application NumberN/A
Marketing CategoryN/A
Route of AdministrationORAL
Effective DateDecember 2, 2020
Generic NameCitric Acid and Sodium Citrate

INGREDIENTS (5)

CITRIC ACID MONOHYDRATEActive
Quantity: 640 mg in 5 mL
Code: 2968PHW8QP
Classification: ACTIM
ALCOHOLInactive
Code: 3K9958V90M
Classification: IACT
METHYLPARABENInactive
Code: A2I8C7HI9T
Classification: IACT
PROPYLPARABENInactive
Code: Z8IX2SC1OH
Classification: IACT
TRISODIUM CITRATE DIHYDRATEActive
Quantity: 490 mg in 5 mL
Code: B22547B95K
Classification: ACTIM

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Oracit - FDA Drug Approval Details